Novo Nordisk has long acting Insulin Icodec (weekly injection / LAI287) in phase 2
However, the effect might not be very pronounced during this early stage
Not for type 1 diabetes or diabetic ketoacidosis
reports institutional contracts with Amgen, Applied Therapeutics, AstraZeneca, Biomea, Boehringer Ingelheim, Corcept, Eli Lilly, Fractyl, Kailera, Novo Nordisk, Pfizer, Recordati, Rhythm and Servier, and a consultant role at Baim Institute for Clinical Research, Mediflix, Sanofi and Roche
Section 7: Medvi Side Effects (Safety Profile) GLP-1 medications prescribed through the Medvi healthcare platform carry a well-characterized safety profile established through extensive clinical research
People who take GLP-1 agonists like Ozempic often manage to lose weight as well as regain control over their blood sugar